Reliance Industries Limited (RIL) has gained more than 3 percent hitting a new lifetime high, on September 6, as its subsidiary acquired a majority stake in genomic testing firm Strand Life Sciences for ₹393 crore.
Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.
